← Leaderboards
Muhammad Ashraf
University Of Cincinnati
$27,715,813
Attributed
$36,369,683
Total exposure
15
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$36,369,683 · 15
By mechanism
R01$30,674,306 · 14
R37$5,695,377 · 1
Top collaborators
- Meifeng Xu10 shared
- W Keith Jones9 shared
- Yao Liang Tang9 shared
- Neal L Weintraub9 shared
- Yigang Wang5 shared
Most similar at University Of Cincinnati
Same institution · by research overlap
- Yigang Wang$11,973,905
- Evangelia G Kranias$18,880,856
- Rafeeq Habeebahmed$2,459,856
- Khawaja H Haider$4,240,527
- Fred Douglass Finkelman$18,476,629
Others in their field
Top investigators on “Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$220,248,453
- David Heimbrook · Leidos Biomedical Research, Inc.$161,931,307
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$73,044,559
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$70,591,644
- Michelle M Le Beau · University Of Chicago$70,506,423
Research focus
Stem CellsCellsCardiacRepairedMyocardiumHeartMyocardial InfarctionTransplantationIn VivoNatural RegenerationCell SurvivalBaseCardiac MyocytesIn VitroMolecularBone MarrowInfarctionMyocardial IschemiaEngraftmentPreconditioningTissuesMicrornasDesignEnvironment
Grant awards (71)
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$499,954
R01 · FY2021 · AR
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair$621,413
R01 · FY2020 · HL
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$515,417
R01 · FY2020 · AR
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair$621,413
R01 · FY2019 · HL
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$528,617
R01 · FY2018 · AR
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair$621,413
R01 · FY2017 · HL
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$541,817
R01 · FY2017 · AR
Integration Free IPS Cells-Derived Progenitors for Cardiac Regeneration$768,967
R01 · FY2016 · HL · contact PI
NF-kB-dependent miRNAs in Cardioprotection and Regeneration$635,285
R01 · FY2016 · HL
Notch1/miR-322 Axis in Stem Cell Mediated Vascular Repair$634,413
R01 · FY2016 · HL
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors$528,394
R01 · FY2016 · AR
MicroRNA as mediators of angiogenesis & ischemic myocardial repair$498,846
R01 · FY2016 · HL
Integration Free IPS Cells-Derived Progenitors for Cardiac Regeneration$733,661
R01 · FY2015 · HL · contact PI
iPS cells-derived progenitor cells for angiomyogenesis$714,954
R01 · FY2015 · HL
NF-kB-dependent miRNAs in Cardioprotection and Regeneration$651,092
R01 · FY2015 · HL
MicroRNA as mediators of angiogenesis & ischemic myocardial repair$491,362
R01 · FY2015 · HL
iPS cells-derived progenitor cells for angiomyogenesis$717,972
R01 · FY2014 · HL
NF-kB-dependent miRNAs in Cardioprotection and Regeneration$664,333
R01 · FY2014 · HL
MicroRNA as mediators of angiogenesis & ischemic myocardial repair$488,868
R01 · FY2014 · HL
Wnt11 signaling in stem cell survival and cardiac regeneration$380,804
R01 · FY2014 · HL
NF-kB-dependent miRNAs in Cardioprotection and Regeneration$623,695
R01 · FY2013 · HL
PDE5A Inhibition Stimulates Stem Cell Survival & Differentiation$593,226
R01 · FY2013 · HL · contact PI
iPS cells-derived progenitor cells for angiomyogenesis$586,010
R01 · FY2013 · HL
MicroRNA as mediators of angiogenesis & ischemic myocardial repair$474,901
R01 · FY2013 · HL
Stem Cells in Cardiac Repair and Angiogenesis$442,775
R37 · FY2013 · HL · contact PI
Wnt11 signaling in stem cell survival and cardiac regeneration$369,923
R01 · FY2013 · HL
Stem Cells in Cardiac Repair and Angiogenesis$137,036
R37 · FY2013 · HL · contact PI
PDE5A Inhibition Stimulates Stem Cell Survival & Differentiation$26,090
R01 · FY2013 · HL · contact PI
Angiomyogenesis With Myoblast Derived iPS Cells$683,749
R01 · FY2012 · HL · contact PI
PDE5A Inhibition Stimulates Stem Cell Survival & Differentiation$639,138
R01 · FY2012 · HL · contact PI
Stem Cells in Cardiac Repair and Angiogenesis$606,194
R37 · FY2012 · HL · contact PI
MicroRNA as mediators of angiogenesis & ischemic myocardial repair$542,796
R01 · FY2012 · HL
Wnt11 signaling in stem cell survival and cardiac regeneration$388,575
R01 · FY2012 · HL
iPS cells-derived progenitor cells for angiomyogenesis$286,122
R01 · FY2012 · HL
Angiomyogenesis With Myoblast Derived iPS Cells$683,749
R01 · FY2011 · HL · contact PI
PDE5A Inhibition Stimulates Stem Cell Survival & Differentiation$677,686
R01 · FY2011 · HL · contact PI
iPS cells-derived progenitor cells for angiomyogenesis$563,834
R01 · FY2011 · HL
Cardiac Repair Using Smart Stem Cells$511,857
R01 · FY2011 · HL · contact PI
Wnt11 signaling in stem cell survival and cardiac regeneration$392,500
R01 · FY2011 · HL
Cardiac Repair Using Smart Stem Cells$52,913
R01 · FY2011 · HL · contact PI
PDE5A Inhibition Stimulates Stem Cell Survival & Differentiation$634,310
R01 · FY2010 · HL · contact PI
Stem Cells in Cardiac Repair and Angiogenesis$597,339
R37 · FY2010 · HL · contact PI
Cardiac Repair Using Smart Stem Cells$570,474
R01 · FY2010 · HL · contact PI
Wnt11 signaling in stem cell survival and cardiac regeneration$381,100
R01 · FY2010 · HL
PDE5A Inhibition Stimulates Stem Cell Survival & Differentiation$672,509
R01 · FY2009 · HL · contact PI
Stem Cells in Cardiac Repair and Angiogenesis$571,131
R37 · FY2009 · HL · contact PI
Cardiac Repair Using Smart Stem Cells$567,311
R01 · FY2009 · HL · contact PI
Mechanistic basis of myoblast therapy and angiomyogenesis$556,233
R01 · FY2009 · HL · contact PI
Cardiac Repair Using Smart Stem Cells$587,242
R01 · FY2008 · HL · contact PI
Stem Cells in Cardiac Repair and Angiogenesis$558,358
R37 · FY2008 · HL · contact PI
Mechanistic basis of myoblast therapy and angiomyogenesis$529,231
R01 · FY2008 · HL · contact PI
Mechanistic basis of myoblast therapy and angiomyogenesis$557,855
R01 · FY2007 · HL · contact PI
Cardiac Repair Using Smart Stem Cells$549,989
R01 · FY2007 · HL · contact PI
Stem Cells in Cardiac Repair and Angiogenesis$510,402
R37 · FY2007 · HL · contact PI
Mechanistic basis of myoblast therapy & angiomyogenesis$541,140
R01 · FY2006 · HL · contact PI
Stem Cells in Cardiac Repair and Angiogenesis$510,337
R37 · FY2006 · HL · contact PI
Mitochondrial KATP Channel in Cardioprotection$500,501
R01 · FY2006 · HL · contact PI
Mechanistic basis of myoblast therapy &angiomyogenesis$525,820
R01 · FY2005 · HL
Stem Cells in Cardiac Repair and Angiogenesis$507,393
R37 · FY2005 · HL
Mitochondrial KATP Channel in Cardioprotection$497,616
R01 · FY2005 · HL
Stem cells in cardiac repair and angiogenesis$188,657
R37 · FY2005 · HL
Stem Cells in Cardiac Repair and Angiogenesis$536,962
R37 · FY2004 · HL
Mitochondrial KATP Channel in Cardioprotection$483,124
R01 · FY2004 · HL
Mitochondrial KATP Channel in Cardioprotection$542,049
R01 · FY2003 · HL
Stem Cells in Cardiac Repair and Angiogenesis$528,793
R37 · FY2003 · HL
MYOCARDIAL ISCHEMIC INJURY--MODIFICATION BY DRUG THERAPY$325,567
R01 · FY2003 · HL
Mitochondrial KATP Channel in Cardioprotection$516,386
R01 · FY2002 · HL
MYOCARDIAL ISCHEMIC INJURY--MODIFICATION BY DRUG THERAPY$316,554
R01 · FY2002 · HL
MYOCARDIAL ISCHEMIC INJURY--MODIFICATION BY DRUG THERAPY$324,836
R01 · FY2001 · HL
MYOCARDIAL ISCHEMIC INJURY--MODIFICATION BY DRUG THERAPY$308,380
R01 · FY2000 · HL
ADENOSINE AND CA++ IN MYOCARDIAL PRECONDITIONING$230,320
R01 · FY2000 · HL